Table 1. Demographic, pathological and molecular data of patients.
| Demographic data | |
|---|---|
| Median age (range) | 58.5 (46.0–66.0) |
| Sex | |
| Men | 84 (64%) |
| Women | 48 (36%) |
| Pathological characteristics | |
| Tumour resection | |
| Gross total | 26 (21%) |
| Subtotal | 68 (55%) |
| Partial | 12 (10%) |
| Biopsy | 17 (14%) |
| Tumour grade1 | |
| I | 9 (7%) |
| II | 14 (10%) |
| III | 26 (20%) |
| IV | 83 (63%) |
| Tumour lineage | |
| Astrocytic | 96 (73%) |
| Oligodendroglial (OD) | 29 (22%) |
| Astrocytic with OD differentiation | 7 (5%) |
| Ki-67 grade | |
| Low | 60 (47%) |
| Intermediate | 51 (40%) |
| High | 16 (13%) |
| P53 expression | |
| Low-Intermediate (≤ 60% cells) | 97 (77.6%) |
| High (> 60% cells) | 28 (22.4%) |
| Gene methylation | |
| EPB41L3 | |
| Yes | 29 (29%) |
| No | 71 (71%) |
| RASSF2 | |
| Yes | 10 (10.6%) |
| No | 84 (89.4%) |
| TSP-1 | |
| Yes | 58 (50%) |
| No | 57 (50%) |
1
Grade according to the World Health Organization (WHO) grading system